Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Shanghai Allist Pharmaceuticals Co Ltd (688578)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
91.47 +1.46    +1.62%
15/08 - Closed. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE100005XJ7 
  • Volume: 4,272,833
  • Bid/Ask: 91.48 / 91.48
  • Day's Range: 88.80 - 91.96
Shanghai Allist Pharmaceuticals Co 91.47 +1.46 +1.62%

Shanghai Allist Pharmaceuticals Co Ltd Company Profile

 
Get an in-depth profile of Shanghai Allist Pharmaceuticals Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

1417

Equity Type

ORD

Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.

Contact Information

Address No. 268 Lingxiaohua Road Zhoupu Town
Pudong New Area Shanghai, 201318
China
Phone -
Fax -

Top Executives

Name Age Since Title
Jinhao Du 71 2019 Chairman of the Board & GM
Guo Yang 36 2019 Director
Lijun Wang 44 2023 Employee Representative Supervisor
Feng Xu 60 2019 Deputy GM & Director
Jun Yan 43 2019 Independent Director
Ronggang Xie 39 2019 Director
Ju Qi 73 2019 Director
Xiaofang Zhang 50 2023 Chairman of Supervisory Board
Chao Lu 43 2019 Independent Director
Cong Xu 40 2024 Director
Jie Hu 50 2019 Vice Chairman & Deputy GM
Jiayu Yang 46 2019 Independent Director
Shengming Chu 55 2023 Supervisor
Shengtao Zhu 47 2019 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

688578 Comments

Write your thoughts about Shanghai Allist Pharmaceuticals Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email